Expert Interviews

Tom Martens, MD, Talks about the Vision for CGM as Part of Primary Care for Type 2 Diabetes
June 18, 2021

MOBILE study lead author Tom Martens, MD, talks about the inherent benefits of CGM for T2D patients on basal insulin treated in primary care and also the challenges to this vision of patient care.

Thomas W. Martens, MD: MOBILE Study Findings on CGM vs BGM in T2 Diabetes
June 17, 2021

MOBILE study lead author Thomas W. Martens, MD, discusses results of the study which was designed to capture CGM results in real-world primary care practice.

CGM vs SMBG in Primary Care: What Does the T2D Evidence Say?
June 17, 2021

Patients with T2D see significant improvement in glycemic control using continuous glucose monitoring. MOBILE study lead author Thomas W. Martens, MD, highlights the evidence.